Making commercial arguments using digital media
November 10, 2011Medical Communications
The global climate and the NHS overhaul are placing exceptional pressure on healthcare professionals to cut costs while preserving – …
How can pharma cross the digital chasm?
November 10, 2011Medical Communications
An HR Director once surveyed the diverse jobs I had done (from lab research to international marketing) and asked “What …
Serious about digital?
November 10, 2011Medical Communications
We all know that emails are a quick and cost-effective way of communicating with your target audience but what makes …
Private firm in NHS hospital takeover
November 10, 2011Sales and Marketing Circle Healthcare, Hinchingbrooke, NHS
Circle Healthcare has sealed a deal to take over the running of a debt-ridden NHS hospital in Cambridgeshire. Private firms …
NICE won’t back Faslodex in breast cancer
November 10, 2011Sales and Marketing AstraZeneca, Faslodex, NICE
NICE has not recommended AstraZeneca’s breast cancer drug Faslodex as it says the drug is no better than existing treatments. …
Insight into the Manufacturing of an Auto Injector
November 10, 2011Manufacturing and Production autoinjecto manufacturing, autoinjector, automation, tooling
As the number of biologics coming to market continues to grow, the demand for drug delivery devices such as the …
Boehringer hails hepatitis C candidate
November 9, 2011Sales and Marketing BI201335, Boehringer Ingelheim, HCV, Incivo, Victrelis, hepatitis C
Boehringer Ingelheim believes that one of its investigational drugs for liver disease hepatitis C (HCV) could shorten patients’ treatment time …
Roche’s skin cancer drug receives FDA priority review
November 9, 2011Research and Development, Sales and Marketing Roche, vismodegib
Roche’s skin cancer pill vismodegib will receive a priority review from the FDA which could see it approved within six …
Autoclave Design Flexibility is Feature of Priorclave Stand at Medica1
November 9, 2011Manufacturing and Production
Visitors to the Priorclave stand 1E02 can evaluate first-hand the benefits of models including:
Timothy Wright appointed as global head of development at Novartis Pharmaceuticals
November 9, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis
Novartis has appointed Dr Timothy Wright as the new global head of development of its pharmaceuticals business, effective immediately. Dr …
Pharma manufacturing news in brief
November 9, 2011Manufacturing and Production manufacturing and production news
Nephron earmarks $313m for new US facility, police break up a demonstration at Dr Reddy’s with tear gas, plus updates …
‘Military-inspired’ project wins 2011 Facility of the Year Award
November 9, 2011Manufacturing and Production MedImmune, manufacturing and production
MedImmune’s US manufacturing plant in Frederick, Maryland, has won the 2011 Facility of the Year Award, beating out rival category …
Edge Medical Communications makes two senior appointments
November 9, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edge Medical, Medical comms
Edge Medical Communications has appointed Dr Laurence De-Netto as account director and Dr Elizabeth Rapley as business development manager. Dr …
Amylin to pay up to $1.6 billion to sever ties with Lilly
November 8, 2011Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, R&D, lilly
Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …
Strategic alliance executives
November 8, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTPartners, Strategic alliance executives
Given the extraordinary costs and risks associated with drug discovery and development, it’s not surprising that an increasing number of …
AZ and Targacept’s novel depression drug misses target
November 8, 2011Research and Development, Sales and Marketing AstraZeneca
AstraZeneca and Targacept’s next generation depression drug has failed to meet its primary endpoint in a late-stage trial. The first …
UK pharma downbeat on its future – survey
November 8, 2011Research and Development ABPI, R&D, VBP, rsa
The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …
Organising a successful event
November 8, 2011Sales and Marketing
Company conferences and events have come a long way since we used to be taken out for a short meeting …
Market access – looking back
November 8, 2011Sales and Marketing
Market access is complicated. Multifaceted, multi-discipline, multidimensional, multi-stake-holder, all these multiples make Market Access one of the most challenging and …
Daniel Grau appointed as president of Heptares
November 8, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares
Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors. Mr Grau has been a …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
